SKU: C-1270-5mg
 C32H41N9O4 Solid Powder
$129.99
  • Catalog#: C-1270
  • Targets: PI3K
  • Synonym: PKI587; PKI-587; PKI 587; PF05212384; PF-05212384; PF 05212384; PF5212384; PF-5212384; PF 5212384; Gedatolisib
  • Chemical Name/IUPAC:1-(4-(4-(dimethylamino)piperidine-1-carbonyl)phenyl)-3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)urea
    Technical Data
  • Product Name: PKI-587 (Gedatolisib)
  • Chemical Formula: C32H41N9O4
  • Molecular Weight: 615.72
  • CAS#: 1197160-78-3
  • Appearance: Solid powder
  • Purity: > 99% by HPLC
  • Solubility: Soluble in DMSO
  • Storage: Room temperature for months, or -20ºC for 3 years
    Description
    PKI-587 (Gedatolisib) is an agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. Upon intravenous administration, PI3K/mTOR kinase inhibitor PKI-587 inhibits both PI3K and mTOR kinases, which may result in apoptosis and growth inhibition of cancer cells overexpressing PI3K/mTOR.